An Antimicrobial Resistance Toolkit from Advanced Courses and Scientific Conferences
Antimicrobial resistance (AMR) is one of the most prevalent public health issues worldwide. In the UK, we have increasing rates of methicillin-resistant staphylococcus aureus (MRSA), with infection control becoming a growing burden to the NHS. The problem is even more complex in low and middle-income countries, where general infection control is far more challenging and difficult to implement.
Globally, AMR represents one of our greatest ‘one-health’ challenges that places immense pressure on societies. As antibiotics cease to effectively manage previously treatable infections, AMR will increasingly become a major threat to modern medicine.
Display your AMR Technology, Product and Service
Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.